Cardiac amyloidosis and surgery: What do we know about rare diseases?
Author:
Affiliation:
1. Clinic of Cardiac Surgery University Hospital Zürich Zürich Switzerland
2. Department of Cardiothoracic Surgery The University of the Free State Bloemfontein South Africa
Publisher
Wiley
Subject
Cardiology and Cardiovascular Medicine,Surgery,Pulmonary and Respiratory Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/jocs.15630
Reference12 articles.
1. Regulation (EC) No. 141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products;Official J Eur Comm,2000
2. Council recommendation of 8 June 2009 on an action in the field of rare diseases (2009/C 151/02).Official J Eur Union. 2009;52:7–10.http://eurlex.europa.eu/legalcontent/EN/TXT/?uri=OJ:C:2009:151:TOC. Accessed April 30 2021.
3. Orphan Drug Act of 1983. US Food and Drug Administration. January 4 1983.
4. Rare Disease Terminology and Definitions—A Systematic Global Review: Report of the ISPOR Rare Disease Special Interest Group
5. Emerging causes and risk factors of heart failure: amyloidosis, myocarditis, immune checkpoint inhibitors, air pollution, and visceral adipose tissue
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3